Key Segmentation
By Procedure
-
Preimplantation Genetic Screening (PGS)
-
Preimplantation Genetic Diagnosis (PGD)
By Product
-
Reagents and Consumables
-
Instruments
-
Software
By Technology
-
Next Generation Sequencing (NGS)
-
Polymerase Chain Reaction (PCR)
-
Fluorescent In-Situ Hybridization (FISH)
-
Others
By Application
-
Chromosomal Abnormalities
-
X-linked Diseases
-
Embryo Testing
-
Aneuploidy Screening
-
HLA Typing
-
Others
By End-Use
-
Fertility Centers
-
Hospitals
-
Diagnostic Centers
-
Research Centers and Academic Labs
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Preimplantation Genetic Diagnosis (PGD) dominated with approximately 78.41% share in 2025.
North America dominated the Preimplantation Genetic Testing Market.
The Preimplantation Genetic Testing Market is expected to grow at a CAGR of 9.93% from 2026 to 2035.
The Preimplantation Genetic Testing Market was valued at USD 956.90 Million in 2025.
Rising global infertility prevalence creating above-average ART and IVF adoption and NGS technology advancing comprehensive aneuploidy detection.